Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 416-422, 2004. First published December 11, 2003; 10.1373/clinchem.2003.023994
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2003.023994v1
clinchem.2003.023994v2
50/2/416    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feng, Y.
Right arrow Articles by Liu, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feng, Y.
Right arrow Articles by Liu, F.
Related Collections
Right arrow Clinical Immunology
Right arrow Proteomics and Protein Markers
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2004;50:416-422.)
© 2004 American Association for Clinical Chemistry, Inc.

Clinical Immunology

Parallel Detection of Autoantibodies with Microarrays in Rheumatoid Diseases

Yanfei Feng1, Xue Ke1, Rongshui Ma1, Ying Chen1, Gengxi Hu1,2,a and Feizhou Liu1,a

1 Research Center, Shanghai HealthDigit, Co., Ltd., Shanghai 200233, Peoples Republic of China.
2 Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, Peoples Republic of China.

aAddress correspondence to these authors at: Research Center, Shanghai HealthDigit Co., Ltd., 4/F, Bldg. 51, 1089 N. Qinzhou Rd., Shanghai 200233, Peoples Republic of China. Fax 86-021-64957556; e-mail liufeizhou{at}health-digit.com.

Background: Clinical needs often dictate testing for several autoantibodies in a single patient with evidence of autoimmune disease. We developed a microarray containing 15 autoantigens for the detection of autoantibodies in rheumatoid autoimmune diseases.

Methods: We synthesized recombinant centromere protein B, cytokeratin 19, SSA 52-kDa antigen, SSA 60-kDa antigen, SSB antigen, and Jo-1 antigen and prepared anti-nuclear antibody antigens. Cyclic citrullinated peptide, histone, goat IgG for detection of rheumatoid factor, double-stranded DNA, and single-stranded DNA were purchased, as were recombinant small nuclear ribonucleoprotein U1, topoisomerase I, and Smith antigen (Sm). All 15 antigens were of human origin except calf thymus Sm. Proteins were printed on polystyrene. The arrays were incubated with serum samples and then with horseradish peroxidase-conjugated secondary antibodies and chemiluminescent substrates, and light signals were captured by a charge-coupled device camera-based chip reader. Antibodies were quantified by use of calibration curves. Positive samples were confirmed by commercially available methods.

Results: The detection limit of the microarray system was 20 pg of IgG printed on the polystyrene support. More than 85% of the confirmed positive sera were detected as positive with the microarray system based on cutoff values established with the microarray system. The imprecision (CV) of the microarrays was <15% for all 15 autoantibody assays, with the exception of single-stranded DNA (18% and 23%) within and between batches. Characteristic autoantibody patterns were seen in patients with clinical diagnoses of rheumatoid arthritis (n = 83), systemic lupus erythematosus (n = 71), systemic sclerosis (n = 36), polymyositis (n = 38), and Sjogren syndrome (n = 20).

Conclusions: This microarray system provides results similar to those by conventional methods. Assessment of the diagnostic accuracy of the system remains to be done.




The following articles in journals at HighWire Press have cited this article:


Home page
 Mol. Cell. ProteomicsHome page
J. Madoz-Gurpide, R. Kuick, H. Wang, D. E. Misek, and S. M. Hanash
Integral Protein Microarrays for the Identification of Lung Cancer Antigens in Sera That Induce a Humoral Immune Response
Mol. Cell. Proteomics, February 1, 2008; 7(2): 268 - 281.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
P. Angenendt, J. Kreutzberger, J. Glokler, and J. D. Hoheisel
Generation of High Density Protein Microarrays by Cell-free in Situ Expression of Unpurified PCR Products
Mol. Cell. Proteomics, September 1, 2006; 5(9): 1658 - 1666.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
Y Xiang and T Kato
Use of Proteomics in Analysis of Autoimmune Diseases
Lupus, July 1, 2006; 15(7): 431 - 435.
[Abstract] [PDF]

Home page
 CVIHome page
S. R. Binder, M. C. Genovese, J. T. Merrill, R. I. Morris, and A. L. Metzger
Computer-Assisted Pattern Recognition of Autoantibody Results
Clin. Vaccine Immunol., December 1, 2005; 12(12): 1353 - 1357.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.